Teleflex Incorporated TFX has announced a new three-year agreement with Amerinet, Inc., a national healthcare group purchasing organization. Amerinet selected Arrow Peripherally Inserted Central Catheters as part of a multi source agreement. The new agreement begins May 1, 2011 and extends through April 30, 2014.
The Arrow PICC product line includes the recently introduced Arrow EVOLUTION™ PICC with Chlorag+ard™ antimicrobial technology, the first Chlorhexidine-treated peripherally inserted central catheter with both
intraluminal and extraluminal protection. Chlorag+ard technology provides broad spectrum antimicrobial protection against bacterial and fungal colonization.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in